Immutep (IMMP) Current Leases (2019 - 2026)
Immutep's (IMMP) quarterly Current Leases came in at $537247.9 in Q2 2026, up 166.38% on a YoY basis from $201681.4 in Q2 2025, and down 13.83% quarter-over-quarter from $623485.4 in Q4 2025.
Analysis
Immutep (IMMP) Current Leases (2019 - 2026) Analysis & Trends
Immutep (IMMP) has reported Current Leases for 8 consecutive years, with $537247.9 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Leases rose 166.38% year-over-year to $537247.9; the trailing twelve-month figure through Jun 2026 stood at $537247.9 (up 166.38% YoY), and the FY2026 full-year result was $537247.9, up 166.38% from the prior year.
- Current Leases declined to $537247.9 in Q2 2026 per IMMP's latest filing, from $623485.4 in the prior quarter.
- Across five years, Current Leases topped out at $623485.4 in Q4 2025 and bottomed at $23059.5 in Q4 2022.
- Historically, Current Leases has averaged $272241.0 across 5 years, with a median of $255726.5 in 2024.
- The sharpest annual moves came in 2022 and 2023: Current Leases tumbled 71.24% in 2022, then jumped 1331.05% in 2023.
- Over 5 years, Current Leases stood at $23059.5 in 2022, then surged by 1331.05% to $329992.3 in 2023, then slipped by 22.51% to $255726.5 in 2024, then soared by 143.81% to $623485.4 in 2025, then dropped by 13.83% to $537247.9 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $537247.9, $623485.4, and $201681.4 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 12.38 Mn |
| 10 | Immutep | 51.68 Mn | 51.68 Mn | - | 537,247.89 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 537,247.89 |
| Dec 31, 2025 | 623,485.44 |
| Jun 30, 2025 | 201,681.38 |
| Dec 31, 2024 | 255,726.46 |
| Jun 30, 2024 | 263,220.31 |
| Dec 31, 2023 | 329,992.28 |
| Jun 30, 2023 | 138,762.99 |
| Dec 31, 2022 | 23,059.49 |
| Jun 30, 2022 | 76,993.11 |
| Dec 31, 2021 | 80,178.79 |
| Jun 30, 2021 | 61,691.43 |
| Dec 31, 2020 | 67,858.52 |
| Jun 30, 2020 | 87,151.94 |
| Dec 31, 2019 | 98,573.23 |